$0.77 -0.02 (-2.65%)
11/25/2009 2:17 PM

Antigenics, Inc. (AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Featured Broker Partners